# Fixed Versus Flexible Gonadotropin-releasing Hormone (GnRH) Antagonist Initiation

> **NCT01005784** · PHASE4 · COMPLETED · sponsor: **Aristotle University Of Thessaloniki** · enrollment: 146 (actual)

## Conditions studied

- Subfertility

## Interventions

- **DRUG:** Cetrorelix (Cetrotide)
- **DRUG:** Cetrorelix (Cetrotide)

## Key facts

- **NCT ID:** NCT01005784
- **Lead sponsor:** Aristotle University Of Thessaloniki
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** 2008-01
- **Final completion:** 2008-03
- **Target enrollment:** 146 (ACTUAL)
- **Last updated:** 2009-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01005784

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01005784, "Fixed Versus Flexible Gonadotropin-releasing Hormone (GnRH) Antagonist Initiation". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01005784. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*